Coronavirus disease 2019 (COVID-19)
Evidence
This page contains a snapshot of featured content which highlights evidence addressing key clinical questions including areas of uncertainty. Please see the main topic reference list for details of all sources underpinning this topic.
Cochrane Clinical Answers
Cochrane Clinical Answers (CCAs) provide a readable, digestible, clinically focused entry point to rigorous research from Cochrane systematic reviews. They are designed to be actionable and to inform decision making at the point of care and have been added to relevant sections of the main Best Practice text.
- What are the effects of quarantine for individuals traveling from a country with a declared COVID‐19 outbreak?
- What are the effects of quarantine plus other measures for controlling the spread of COVID‐19
- For non‐hospitalized people with COVID‐19 at risk of progression, do prophylactic anticoagulants improve outcomes?
- What are the effects of antiplatelet agents for the treatment of adults with COVID‐19?
- For adults with COVID‐19, what are the effects of the interleukin‐6 blocking agents tocilizumab and sarilumab?
O uso deste conteúdo está sujeito ao nosso aviso legal